Outcomes of algorithm‐based modifications of insulinotherapy during exercise in MDI vs insulin pump‐treated children with type 1 diabetes: Results from the TREAD‐DIAB study. Issue 8 (2nd March 2017)

• Record Type: Journal Article
• Authors: Moniotte, S; Owen, M; Barrea, T; Robert, A; Lysy, PA
• Is Part Of: Pediatric diabetes. Volume 18:Issue 8(2017)
• Page Start: 925
• Page End: 933
• Publication Date: 2017-03-02
• Subjects: adolescents -- algorithm -- CGM -- children -- exercise -- treadmill -- type 1 diabetes; Diabetes in children -- Periodicals; 616.462
• DOI: 10.1111/pedi.12509
• Languages: English
• ISSNs: 1399-543X

Abstract

Abstract : Objectives: To evaluate the evolution of subcutaneous glucose (SG) after a standardized aerobic exercise in children and adolescents treated with continuous subcutaneous insulin infusion (CSII) or multiple daily injection (MDI) regimen before and after adaptation of insulin doses. Research Design and Methods: Eleven CSII‐ and 13 MDI‐treated patients performed 2 30‐minute sessions of moderate to vigorous (70% of age‐based maximal heart rate) exercise on a treadmill under continuous glucose monitoring (CGM). First sessions were scheduled without insulin modification (TT#1) while patients performed second sessions (TT#2) after preemptive algorithm‐based insulin dose modifications. Results: While insulin adaptations did not modify immediate postexercise drops in blood glucose during TT#2 in either group, CSII‐treated patients had their glucose control improved during TT#2 (mean of 141 ± 56 mg/dL vs 144 ± 80 mg/dL in TT#1; P < .05) with up to 86% of SG levels within targets during 16 hours postexercise. Contrarily, SG levels did not normalize during TT#2 in MDI‐treated patients who experienced higher rates of hyperglycemia during the afternoon snack. As compared with TT#1, CSII‐treated patients had reduced rates of hypoglycemia during 4 hours post‐TT#2 (from 19.5% to 2.1%; P < .01) and had shorter duration of nocturnal hypoglycemia (35.5 ± 12.8 vs 204.7 ± 165 minutes; P = .04) whereas in the MDI group no changes in percentages of hypoglycemia were observed during TT#2. Conclusion: In our pediatric cohort, algorithmic adaptations of insulin doses were associated with better outcomes in terms of postexercise glucose control in patients with CSII therapy but not with MDI treatment.